Nutrition for Sustained Energy
Naked - The Art of Naked
Vaseline Intensive Care
Green Machine - Naked

FDA Warns Against Unproven MS Treatment

Written by Michael Richardson

The FDA issued a warning to health care professionals and their patients on recently about injuries and death associated with a multiple sclerosis (MS) treatment called “liberation therapy” by some.

“Liberation therapy,” an experimental procedure, is meant to treat chronic cerebrospinal venous insufficiency (CCSVI), a narrowing of veins in the neck and chest, which may be a cause of MS or may contribute to the disease’s progression. The recent FDA news release, however, said “studies exploring a link between MS and CCSVI are inconclusive, and the criteria used to diagnose CCSVI have not been adequately established.” The procedure uses balloon angioplasty devices or stents to widen the narrowed veins in the chest and neck. But the procedure can lead to a myriad of health problems, according to the FDA.

“The FDA has learned of death, stroke, detachment and migration of the stents, damage to the treated vein, blood clots, cranial nerve damage and abdominal bleeding associated with the experimental procedure. Balloon angioplasty devices and stents have not been approved by the FDA for use in treating CCSVI.”

The cause of MS remains unknown, though its damaging effects are well understood. The disease damages the ability of nerve cells in the brain and spinal cord to communicate with each other, and can lead to a host of problems, such as loss of sensitivity, loss of balance, speech issues, cognitive impairment and depression, to name a few. MS gradually deteriorates neurological function.

350-080 640-864 C2180-317 117-201 70-485 70-498 98-372 C2020-702 70-466 70-331 EX300 1Z0-060 MB2-701 70-410 200-120 70-410 exam 200-120 exam PMI-SP S90-09A 3203 000-610 010-111 70-488 640-461 70-411 642-427 70-648 70-486 650-987 70-480 70-483 70-412 70-463 C_TSCM42_66 C2010-570 70-410 70-461 70-462 70-685 70-247 70-332 HP2-E59 70-336 70-459 98-365 MB6-869 MB7-701 70-485 70-498 98-372 C2020-702 70-178 70-640 CV0-001 MB6-872 70-410 70-461 70-462 70-685 70-247 70-332 HP2-E59 70-336 70-459 98-365 MB6-869 MB7-701 70-485 70-498 98-372 C2020-702 70-178 70-640 CV0-001 MB6-872 70-410 70-461 70-462 200-120 70-488 MB2-703 70-411 MB5-705 C_TADM51_731 70-346 70-486 70-347 70-480 70-483 70-412 70-463 MB2-700 70-417 C_TAW12_731 400-101 MB2-702 70-487 70-243 70-463 MB2-700 70-417 C_TAW12_731 400-101 MB2-702 70-487
Article Reviewed: June 1, 2012
Copyright © 2015 Healthy Magazine

Michael Richardson is an experienced writer, reporter, and interviewer. His writing has appeared in many publications, including KSL, Deseret News, BYU's Family Connections Magazine, and now, Healthy Magazine. Michael is involved in promoting the ideas of social entrepreneurship and solution journalism. And, when he's not saving the planet through his social journalistic ventures, Michael revels in exploring the latest developments in the field of healthcare, its history, its advancements, and where we will be tomorrow.

Find him on

VISIT WEBSITE

Related Articles
The Annual Report to the Nation on the Status of Cancer highlights concerns with HPV-related cancers
Article Reviewed: January 9, 2013
AAD Dermatologists identify five skin health treatments and procedures that consumers may not need
Article Reviewed: December 10, 2013
Here's possibly more than you've ever wanted to know about your appendix
Article Reviewed: December 10, 2013
Human Microbiome Project: Benevolent Bacteria, Miraculous Microbes
Article Reviewed: August 8, 2012
Article Reviewed: July 25, 2013